Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort
about
Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionDiagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic reviewWhen Prostate Cancer Circulates in the BloodstreamProstate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersmiR-182, of the miR-183 cluster family, is packaged in exosomes and is detected in human exosomes from serum, breast cells and prostate cellsmiRNAs associated with prostate cancer risk and progressionDevelopment of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy.Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.A circulating miRNA assay as a first-line test for prostate cancer screeningCirculating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.Emerging biomarkers in the diagnosis of prostate cancer.An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer.MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1.
P2860
Q26742027-981F7E9F-4715-4D81-BC84-E5D9B0C9AC8DQ26748872-0F07132B-7DBC-4DB2-A8D3-642348936F2BQ26768470-9867BFED-F259-4AEA-8590-E3206B4665ECQ28075610-2F4EEBB4-EBEA-474C-90FD-77D857160C5EQ28829628-47FBD078-C919-439C-BC36-B4202A30A2E5Q30235186-B311499A-C35C-4FB6-BA3B-6E9A8EBC6FCFQ36850977-B848A8E5-AC1F-4C7E-B9C7-F8F76969B8DFQ39171785-6B4E1BC0-1190-4195-B382-90C5453FAD3CQ39346497-3832768B-F97C-456E-A26C-76B4E8760C4FQ40377436-79238333-F4DA-4114-8258-D3FF86BA4764Q41073571-41B61B88-875A-4481-8965-BAB0B4BFA642Q48332469-42C03ECD-A021-4F5A-AAAD-24C4D288A28CQ52719567-973708B0-AC80-46FA-9B75-3099A6737E9DQ54964875-30334B2C-3B3D-4733-A7AE-3B1ED41C1EA1Q55285194-C5DD3412-AADB-475A-89C7-C447DAB8FC18Q55425620-47CD243A-C2D6-4FFB-A719-6D3AE53C316B
P2860
Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@ast
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@en
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@nl
type
label
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@ast
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@en
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@nl
prefLabel
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@ast
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@en
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@nl
P2093
P2860
P3181
P1433
P1476
Elevated serum microRNA levels ...... ncer in a retrospective cohort
@en
P2093
Brittany L Mihelich
Donna M Peehl
Joseph C Maranville
Larisa Nonn
Rosalie Nolley
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0124245
P407
P577
2015-01-01T00:00:00Z